Interplay Between MiRNAs and Host Genes and Their Role in Cancer

Overview

Journal Brief Funct Genomics

Publisher Oxford University Press

Date 2019 Feb 21

PMID 30785618

Citations 69

Authors

Baohong Liu

Yu Shyr

Jianping Cai

Qi Liu

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are small endogenous non-coding functional RNAs that post-transcriptionally regulate gene expression. They play essential roles in nearly all biological processes including cell development and differentiation, DNA damage repair, cell death as well as intercellular communication. They are highly involved in cancer, acting as tumor suppressors and/or promoters to modulate cell proliferation, epithelial-mesenchymal transition and tumor invasion and metastasis. Recent studies have shown that more than half of miRNAs are located within protein-coding or non-coding genes. Intragenic miRNAs and their host genes either share the promoter or have independent transcription. Meanwhile, miRNAs work as partners or antagonists of their host genes by fine-tuning their target genes functionally associated with host genes. This review outlined the complicated relationship between intragenic miRNAs and host genes. Focusing on miRNAs known as oncogenes or tumor suppressors in specific cancer types, it studied co-expression relationships between these miRNAs and host genes in the cancer types using TCGA data sets, which validated previous findings and revealed common, tumor-specific and even subtype-specific patterns. These observations will help understand the function of intragenic miRNAs and further develop miRNA therapeutics in cancer.

Citing Articles

Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma.

Yokoi K, Wang J, Yoshioka Y, Fujisawa Y, Fujimoto M, Ochiya T Acta Derm Venereol. 2025; 105:adv40902.

PMID: 40001341 PMC: 11877856. DOI: 10.2340/actadv.v105.40902.

Unraveling the microRNAs Involved in Fasciolosis: Master Regulators of the Host-Parasite Crosstalk.

Barrero-Torres D, Herrera-Torres G, Perez J, Martinez-Moreno A, Martinez-Moreno F, Flores-Velazquez L Int J Mol Sci. 2025; 26(1.

PMID: 39796061 PMC: 11719827. DOI: 10.3390/ijms26010204.

miR-198 targets : implications for oral squamous cell carcinoma pathogenesis.

Kaushik P, Mishra R, Gopal C, Kumar A Front Oncol. 2024; 14:1485802.

PMID: 39697236 PMC: 11652479. DOI: 10.3389/fonc.2024.1485802.

Mechanistic Insights of hsa-mir-301a Regulation by Tobacco Smoke in Lung Squamous Cell Carcinoma: Evidence From Bioinformatics Analysis.

Pustylnyak V, Perevalova A, Gulyaeva L Bioinform Biol Insights. 2024; 18:11779322241302168.

PMID: 39619736 PMC: 11605766. DOI: 10.1177/11779322241302168.

MBNL splicing factors regulate the microtranscriptome of skeletal muscles.

Piasecka A, Szczesniak M, Sekrecki M, Kajdasz A, Sznajder L, Baud A Nucleic Acids Res. 2024; 52(19):12055-12073.

PMID: 39258536 PMC: 11514471. DOI: 10.1093/nar/gkae774.

References

Bischoff A, Huck B, Keller B, Strotbek M, Schmid S, Boerries M . miR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasion. Cancer Res. 2014; 74(18):5256-65. DOI: 10.1158/0008-5472.CAN-13-3319. View

Baskerville S, Bartel D . Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 2005; 11(3):241-7. PMC: 1370713. DOI: 10.1261/rna.7240905. View

Yan J, Ma C, Gao Y . MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines. Oncol Rep. 2017; 37(5):3146-3154. DOI: 10.3892/or.2017.5566. View

Macfarlane L, Murphy P . MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2011; 11(7):537-61. PMC: 3048316. DOI: 10.2174/138920210793175895. View

Agranat-Tamir L, Shomron N, Sperling J, Sperling R . Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome. Nucleic Acids Res. 2014; 42(7):4640-51. PMC: 3985634. DOI: 10.1093/nar/gkt1413. View

Nguyen D, Chang S . Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs. Int J Mol Sci. 2017; 19(1). PMC: 5796015. DOI: 10.3390/ijms19010065. View

Liu Q, Wang J, Zhao Y, Li C, Stengel K, Acharya P . Identification of active miRNA promoters from nuclear run-on RNA sequencing. Nucleic Acids Res. 2017; 45(13):e121. PMC: 5737662. DOI: 10.1093/nar/gkx318. View

Kasar S, Underbayev C, Yuan Y, Hanlon M, Aly S, Khan H . Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia. Oncogene. 2013; 33(25):3307-15. PMC: 4508006. DOI: 10.1038/onc.2013.291. View

Saito Y, Friedman J, Chihara Y, Egger G, Chuang J, Liang G . Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun. 2009; 379(3):726-31. DOI: 10.1016/j.bbrc.2008.12.098. View

10.

Taylor M, Sossey-Alaoui K, Thompson C, Danielpour D, Schiemann W . TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest. 2012; 123(1):150-63. PMC: 3533297. DOI: 10.1172/JCI64946. View

11.

Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

12.

Grady W, Parkin R, Mitchell P, Lee J, Kim Y, Tsuchiya K . Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene. 2008; 27(27):3880-8. DOI: 10.1038/onc.2008.10. View

13.

Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T . Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int J Cancer. 2009; 127(5):1072-80. DOI: 10.1002/ijc.25143. View

14.

Hu Y, Tang Z, Jiang B, Chen J, Fu Z . miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1. Oncol Lett. 2017; 13(3):1753-1760. PMC: 5403721. DOI: 10.3892/ol.2017.5673. View

15.

Majid S, Dar A, Saini S, Shahryari V, Arora S, Zaman M . miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res. 2012; 19(1):73-84. PMC: 3910324. DOI: 10.1158/1078-0432.CCR-12-2952. View

16.

Li S, Tang P, Lin W . Intronic microRNA: discovery and biological implications. DNA Cell Biol. 2007; 26(4):195-207. DOI: 10.1089/dna.2006.0558. View

17.

Sundaram G, Common J, Gopal F, Srikanta S, Lakshman K, Lunny D . 'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature. 2013; 495(7439):103-6. DOI: 10.1038/nature11890. View

18.

Frixa T, Sacconi A, Cioce M, Roscilli G, Ferrara F, Aurisicchio L . MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration. Carcinogenesis. 2017; 39(2):293-304. DOI: 10.1093/carcin/bgx134. View

19.

Zhang B, Pan X, Cobb G, Anderson T . microRNAs as oncogenes and tumor suppressors. Dev Biol. 2006; 302(1):1-12. DOI: 10.1016/j.ydbio.2006.08.028. View

20.

Georgakilas G, Vlachos I, Paraskevopoulou M, Yang P, Zhang Y, Economides A . microTSS: accurate microRNA transcription start site identification reveals a significant number of divergent pri-miRNAs. Nat Commun. 2014; 5:5700. DOI: 10.1038/ncomms6700. View